Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-45762
Invest New Drugs 2017 Dec 01;356:820-826. doi: 10.1007/s10637-017-0505-5.
Show Gene links Show Anatomy links

Mechanisms of cancer cell killing by sea cucumber-derived compounds.

Wargasetia TL , Widodo .


???displayArticle.abstract???
The aim of cancer therapy is to specifically eradicate tumor cells while causing minimal damage to normal tissues and minimal side-effects. Because of this, the use of natural substances with low toxicity is a good option. Sea cucumbers are one of many potential marine animals that contain valuable nutrients and medicinal properties. The medicinal value of sea cucumbers is attributed to the presence of bioactive agents with promising biological and pharmacological properties that include cytotoxic activity, induction of apoptosis, cell cycle arrest, inhibition of tumor growth, anti-metastatic and anti-angiogenic properties, and inhibition of drug resistance. This review discusses the mechanisms of cancer cell death induced by sea cucumber-derived compounds with regard to exploring the potential use of these marine natural products for cancer therapy.

???displayArticle.pubmedLink??? 28920157
???displayArticle.pmcLink??? PMC5694523
???displayArticle.link??? Invest New Drugs


Genes referenced: LOC100887844 LOC115919910

References [+] :
Al Marzouqi, Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts. 2011, Pubmed, Echinobase